These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32043733)

  • 1. Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning.
    Franzmeier N; Koutsouleris N; Benzinger T; Goate A; Karch CM; Fagan AM; McDade E; Duering M; Dichgans M; Levin J; Gordon BA; Lim YY; Masters CL; Rossor M; Fox NC; O'Connor A; Chhatwal J; Salloway S; Danek A; Hassenstab J; Schofield PR; Morris JC; Bateman RJ; ; ; Ewers M
    Alzheimers Dement; 2020 Mar; 16(3):501-511. PubMed ID: 32043733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling autosomal dominant Alzheimer's disease with machine learning.
    Luckett PH; McCullough A; Gordon BA; Strain J; Flores S; Dincer A; McCarthy J; Kuffner T; Stern A; Meeker KL; Berman SB; Chhatwal JP; Cruchaga C; Fagan AM; Farlow MR; Fox NC; Jucker M; Levin J; Masters CL; Mori H; Noble JM; Salloway S; Schofield PR; Brickman AM; Brooks WS; Cash DM; Fulham MJ; Ghetti B; Jack CR; Vöglein J; Klunk W; Koeppe R; Oh H; Su Y; Weiner M; Wang Q; Swisher L; Marcus D; Koudelis D; Joseph-Mathurin N; Cash L; Hornbeck R; Xiong C; Perrin RJ; Karch CM; Hassenstab J; McDade E; Morris JC; Benzinger TLS; Bateman RJ; Ances BM;
    Alzheimers Dement; 2021 Jun; 17(6):1005-1016. PubMed ID: 33480178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.
    Vogel JW; Vachon-Presseau E; Pichet Binette A; Tam A; Orban P; La Joie R; Savard M; Picard C; Poirier J; Bellec P; Breitner JCS; Villeneuve S;
    Brain; 2018 Jun; 141(6):1871-1883. PubMed ID: 29688388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.
    Franzmeier N; Düzel E; Jessen F; Buerger K; Levin J; Duering M; Dichgans M; Haass C; Suárez-Calvet M; Fagan AM; Paumier K; Benzinger T; Masters CL; Morris JC; Perneczky R; Janowitz D; Catak C; Wolfsgruber S; Wagner M; Teipel S; Kilimann I; Ramirez A; Rossor M; Jucker M; Chhatwal J; Spottke A; Boecker H; Brosseron F; Falkai P; Fliessbach K; Heneka MT; Laske C; Nestor P; Peters O; Fuentes M; Menne F; Priller J; Spruth EJ; Franke C; Schneider A; Kofler B; Westerteicher C; Speck O; Wiltfang J; Bartels C; Araque Caballero MÁ; Metzger C; Bittner D; Weiner M; Lee JH; Salloway S; Danek A; Goate A; Schofield PR; Bateman RJ; Ewers M
    Brain; 2018 Apr; 141(4):1186-1200. PubMed ID: 29462334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
    Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
    J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - Beyond classical regression.
    Teipel SJ; Kurth J; Krause B; Grothe MJ;
    Neuroimage Clin; 2015; 8():583-93. PubMed ID: 26199870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.
    Marizzoni M; Ferrari C; Jovicich J; Albani D; Babiloni C; Cavaliere L; Didic M; Forloni G; Galluzzi S; Hoffmann KT; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Ribaldi F; Rossini PM; Schönknecht P; Salvatore M; Soricelli A; Hensch T; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
    J Alzheimers Dis; 2019; 69(1):3-14. PubMed ID: 29914031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
    Dukart J; Sambataro F; Bertolino A
    J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
    Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
    PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease.
    Beyer L; Schnabel J; Kazmierczak P; Ewers M; Schönecker S; Prix C; Meyer-Wilmes J; Unterrainer M; Catak C; Pogarell O; Perneczky R; Albert NL; Bartenstein P; Danek A; Buerger K; Levin J; Rominger A; Brendel M
    Neuroimage Clin; 2019; 24():101949. PubMed ID: 31398553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatic Prediction of Cognitive and Functional Decline Can Significantly Decrease the Number of Subjects Required for Clinical Trials in Early Alzheimer's Disease.
    Shafiee N; Dadar M; Ducharme S; Collins DL;
    J Alzheimers Dis; 2021; 84(3):1071-1078. PubMed ID: 34602478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects.
    Araque Caballero MÁ; Klöppel S; Dichgans M; Ewers M;
    J Alzheimers Dis; 2017; 55(1):343-358. PubMed ID: 27662291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.